Malignant Hyperthermia Clinical Trial
Official title:
Molecular Genetics Study on Screening of Malignant Hyperthermia Susceptible Individuals
This study intends to target patients who underwent surgery under general anesthesia during the study period and developed malignant hyperthermia during or after surgery. Therefore, the total sample size was estimated to be about 50 people based on the past incidence of this rare disease. Every year, about 20 patients and their families who developed malignant hyperthermia during or after surgery will participate in this nationwide study (estimated by the current incidence of malignant hyperthermia), and about 1-5 patients will be admitted to Peking University Third Hospital participate in this research. Relevant specimens were collected from malignant hyperthermia (MH) patients and their family members for genetic analysis to determine the mutation of MH-related pathogenic gene loci.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05036148 -
Malignant Hyperthermia in Czech Republic: Description of the Biggest Slavonic Group of Patients Investigated for Risk of Malignant Hyperthermia
|
||
| Withdrawn |
NCT02561598 -
A Case Control Study of Patients With Diagnosis of Malignant Hyperthermia
|
||
| Withdrawn |
NCT01624558 -
Effectiveness of Carbon Filters to Reduce the Anesthetic Gas Concentration in an Anesthetized Patient
|
N/A | |
| Recruiting |
NCT04474860 -
Gene Mutation Spectrum of Malignant Hyperthermia in China
|
||
| Active, not recruiting |
NCT03964870 -
Spanish Registry of RYR1 and CACNA1S Polymorphisms
|
||
| Recruiting |
NCT04610619 -
Multisystem Features of Malignant Hyperthermia or Rhabdomyolysis Related to RYR1 Variants
|
||
| Terminated |
NCT02964481 -
Malignant Hyperthermia Registry and Genetic Testing
|